CVS Health said it has made a series of executive leadership assignments to support the company’s continued focus on innovation and strategic growth.
Alan Lotvin, evp/CVS Health, has been appointed president of CVS Caremark, and will also have oversight of CVS Specialty and CVS Kidney Care. Lotvin previously led CVS Health’s transformation efforts.
Jonathan Mayhew has been appointed evp/transformation, and will be responsible for the transformation product portfolio. Mayhew has diverse health care experience, most recently serving as svp/Aetna Markets organization.
Alec Cunningham has been appointed evp/chief operating officer for the Aetna business and will lead an expanded organization that will focus on Medicare Advantage and government programs overall.
In addition, Derica Rice, evp/president, CVS Caremark, will depart the company. Derica will remain with the company through February to help ensure a seamless transition.
“We have set a clear and bold path for CVS Health to be the most consumer-centric health company and transform the way care is delivered, and we have laid a strong foundation for growth following more than a year of successfully integrating the Aetna business,” said Larry Merlo, president and CEO, CVS Health. “As we continue to innovate and execute we will stay close to the markets we serve and respond to the needs of our clients. The assignments announced today place our leaders in areas where their unique experience and deep business relationships will help us deliver on our core growth initiatives and transformation strategies.”